OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
BörsenkürzelOSUR
Name des UnternehmensOraSure Technologies Inc
IPO-datumNov 17, 1986
CEOMs. Carrie Eglinton Manner
Anzahl der mitarbeiter501
WertpapierartOrdinary Share
GeschäftsjahresendeNov 17
Addresse220 E First St
StadtBETHLEHEM
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl18015
Telefon15036416115
Websitehttps://www.orasure.com/
BörsenkürzelOSUR
IPO-datumNov 17, 1986
CEOMs. Carrie Eglinton Manner
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten